Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Nitrofural is a topical antibacterial for the prevention and treatment of bacterial infections of the skin. Nitrofural or nitrofurazone is a topical anti-infective agent effective against gram-negative and gram-positive bacteria.
- Mechanism
- Curator reviewed
The exact mechanism of action is unknown. Nitrofurazone inhibits several bacterial enzymes, especially those involved in the aerobic and anaerobic degradation of glucose and pyruvate. This activity is believed also to affect pyruvate dehydrogenase, citrate synthetase, malate dehydrogenase, glutathione reductase, and pyruvate decarboxylase.
- Primary indication
- For the treatment of bacterial skin infections including pyodermas, infected dermatoses and infections of cuts, wounds, burns and ulcers due to susceptible organisms.Curator reviewed · 1 structured indication
- Formula / weight
- C6H6N4O4 · 198.1362 g/mol (avg)
- Also known as
- Furacilin · Nitrofurazone
Resolves to
IAIWVQXQOWNYOU-FPYGCLRLSA-NSMILESNC(=O)N\N=C\C1=CC=C(O1)[N+]([O-])=OWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Nitrofural, and which of those have an active Phase 3 trial?